---
schema_version: "secwatch.filing_event.v1"
accession: "0001999371-25-007734"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T07:55:20.472639+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tonix appoints former EVP James Hunter to Board; 7,740 option grant at $34.54

## Summary
- Appointment effective June 12, 2025; Hunter served as EVP Commercial from June 2023 to Dec 2024.
- Received 7,740 stock options at $34.54, vesting at 2026 annual shareholder meeting.
- Hunter led launch of Tonix Medicines and migraine asset acquisitions Zembrace and Tosymra.
- Board addition strengthens commercial expertise ahead of potential TNX-102 SL fibromyalgia launch; PDUFA Aug 15, 2025.
- Not independent under NASDAQ standards due to prior consulting and employment compensation.

## SEC filing metadata
- accession: 0001999371-25-007734
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000199937125007734/0001999371-25-007734-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000199937125007734/tnxp-8k_061325.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999371-25-007734
- JSON: https://secwatch.observer/filing/0001999371-25-007734.json
- Plain text: https://secwatch.observer/filing/0001999371-25-007734.txt

## Key facts
- Executive change
  James Hunter was appointed as member of the Board at Tonix Pharmaceuticals Holding Corp..
  - Action: appointed
  - Role: member of the Board
  source text: appointed James Hunter as a member of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000199937125007734/0001999371-25-007734-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.